Literature DB >> 21789065

How close are we to establishing standards of lymphadenectomy for invasive bladder cancer?

Pankaj P Dangle1, Robert R Bahnson, Kamal S Pohar.   

Abstract

Radical cystectomy and lymphadenectomy is an accepted standard of care for muscle-invasive bladder cancer. Although the absolute limits of lymphadenectomy have not been standardized a growing body of evidence supports an improvement in nodal staging and survival from an extended lymphadenectomy. The benefit has been reported for both node negative and node positive patients. This review focuses on lymph node mapping, factors that influence total lymph node count and the optimal number of lymph nodes that should be removed at lymphadenectomy.

Entities:  

Keywords:  anatomic template; lymph node excision; urinary bladder neoplasm

Year:  2009        PMID: 21789065      PMCID: PMC3126060          DOI: 10.1177/1756287209346832

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  32 in total

1.  Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens.

Authors:  B H Bochner; H W Herr; V E Reuter
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  Superiority of ratio based lymph node staging for bladder cancer.

Authors:  Harry W Herr
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

3.  The impact of primary stage on survival in patients with lymph node positive bladder cancer.

Authors:  J Vieweg; J E Gschwend; H W Herr; W R Fair
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

4.  Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.

Authors:  R D Mills; W H Turner; A Fleischmann; R Markwalder; G N Thalmann; U E Studer
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

5.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

6.  Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

Authors:  Harry W Herr; Bernard H Bochner; Guido Dalbagni; S Machele Donat; Victor E Reuter; Dean F Bajorin
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

7.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Authors:  Badrinath R Konety; Sue A Joslyn; Michael A O'Donnell
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

8.  Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study.

Authors:  J Leissner; M A Ghoneim; H Abol-Enein; J W Thüroff; L Franzaring; M Fisch; H Schulze; G Managadze; E P Allhoff; M A el-Baz; H Kastendieck; P Buhtz; S Kropf; R Hohenfellner; H K Wolf
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

9.  The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results.

Authors:  S P Lerner; D G Skinner; G Lieskovsky; S D Boyd; S L Groshen; A Ziogas; E Skinner; P Nichols; B Hopwood
Journal:  J Urol       Date:  1993-04       Impact factor: 7.450

10.  Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.

Authors:  John P Stein; Jie Cai; Susan Groshen; Donald G Skinner
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

View more
  2 in total

1.  Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancer.

Authors:  Ahmed A Hussein; Nobuyuki Hinata; Shiva Dibaj; Paul R May; Justen D Kozlowski; Hassan Abol-Enein; Ronney Abaza; Daniel Eun; Mohamed S Khan; James L Mohler; Piyush Agarwal; Kamal Pohar; Richard Sarle; Ronald Boris; Sridhar S Mane; Alan Hutson; Khurshid A Guru
Journal:  BJU Int       Date:  2017-01-18       Impact factor: 5.588

2.  Seeking a standard for adequate pathologic lymph node staging in primary bladder carcinoma.

Authors:  Lu Wang; Kumaran Mudaliar; Vikas Mehta; Güliz A Barkan; Marcus L Quek; Robert C Flanigan; Maria M Picken
Journal:  Virchows Arch       Date:  2014-04-04       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.